|
|
Filaria infections
|
|
Among the parasitic diseases that result from an infection with filarial nematodes,
onchocerciasis
and
lymphatic filariasis
are the two most prevalent diseases,
with ~17 million and ~120 million people being infected, respectively.
Both diseases can substantially impair the individual
(pathology, increased mortality) and the population (socioeconomic development)
and are subject to major intervention programs by the World Health Organization
(WHO).
The Onchocerciasis Control Programme
(OCP),
initiated in 1974
in seven West African countries and performed over an extended area until the end of 2002,
was based on vector control by aerial application of larvicides.
Its successor program, the African Programme for Onchocerciasis Control
(APOC),
relies mainly on mass drug administration of the microfilaricide ivermectin.
The Global Programme to Eliminate Lymphatic Filariasis
(GPELF)
was launched in 1998
and is based on mass drug administration of various microfilaricides.
With our work, with the methods of modeling and simulation,
we try to support the control of these diseases,
to improve our understanding of what the parasite makes persisting,
and thus, to understand how we can optimize the control of these diseases.
|
|
|
|
Responsable de cette page:
|
Dr. H.-P. Duerr
|
|
Webmaster:
|
Prof. Dr. M. Eichner
(dernière modification de cette page:
13 juli 2009)
|
|
Traduit en français par:
|
Claire Le Roux,
Université de Valenciennes et du Hainaut Cambraisis (UVHC),
Institut des Sciences et Techniques (ISTV), France
|
|
Avertissement:
|
L'Université Eberhard Karl de Tübingen,
le Centre Hospitalier Universitaire de Tübingen,
le Département de Biométrie Médicale (IMB),
ainsi que les auteurs de cette page déclinent toute responsabilité pour le contenu des pages auxquelles cette page renvoie
|
Vous êtes le
éme visiteur de notre site.
|
|
|
|
|
